Wang Y, Ge H, Wei X, Zhao X (2022a) Research progress on antibiotic resistance of Salmonella
Tagrisso (osimertinib) Disease area(s): Oncology Manufacturer(s): AstraZeneca 2024 Sales (USD): $6.58 billion Why it sold so well: In 2024, AstraZenecas EGFR-TKI Tagrisso registered $6.58 billion in global sales, reflecting a 13% year-over-year increase
Part of their defense is that the doctors knew of the side effects and had an obligation to inform the patients
For readers comparing a GLP-1 probiotic supplement, Boost Synergy is best understood as a microbiome-supportive formula designed to support mucosal integrity, short-chain fatty acid production, gut barrier stability, and the broader ecosystem behind natural metabolic signaling
To determine the specific acyl-carnitine species that were consistently elevated across the subgroup of patients with consistently abnormal acyl-carnitine panels, we examined the first two acyl-carnitine panels measured for each patient
These findings together suggest that NAC, particularly alone or combined with IFN-, enhances ER stress response in endometriotic cells